Navigation Links
Conseco Shareholders Re-Elect 10 Directors, Approve Two Amendments To Certificate Of Incorporation And Ratify Independent Registered Public Accounting Firm
Date:5/21/2008

CARMEL, Ind., May 21 /PRNewswire-FirstCall/ -- Shareholders of Conseco, Inc. (NYSE: CNO) at the company's annual meeting today:

-- Re-elected 10 directors to serve terms expiring at next year's annual

meeting;

-- Approved amendments to the company's certificate of incorporation to

eliminate the plurality voting standard in uncontested director

elections and declassify the board of directors; and

-- Ratified the appointment of PricewaterhouseCoopers LLP as the company's

independent registered public accounting firm for 2008.

The re-elected directors are: R. Glenn Hilliard, Donna A. James, Debra J. Perry, C. James Prieur, Philip R. Roberts, Neal C. Schneider, Michael S. Shannon, Michael T. Tokarz, John G. Turner, and Doreen A. Wright.

Conseco, Inc.'s insurance companies help protect working American families and seniors from financial adversity: Medicare supplement, long-term care, cancer, heart/stroke and accident policies protect people against major unplanned expenses; annuities and life insurance products help people plan for their financial futures. For more information, visit Conseco's web site at http://www.conseco.com .


'/>"/>
SOURCE Conseco, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Conseco to Host Follow-Up Long-Term Care Conference Call
2. Barta joins Conseco as Senior Vice President, Financial Planning & Analysis; Barra named Senior Vice President, Internal Audit; Clarke to head Investor Relations
3. Conseco Completes Divestiture of Old Block of Fixed and Equity-Indexed Annuities
4. Conseco Sets Earnings Release Date
5. Conseco Reports Third Quarter Results
6. Conseco to Implement Systems and Operational Solution From Long Term Care Group
7. Tongson Joins Conseco as Senior Vice President, Corporate Actuarial
8. Hacker Joins Conseco as Senior Vice President and Treasurer
9. Conseco Files to Formally Extend Due Date for Annual Report on Form 10-K to March 17 and Reschedules Earnings Release and Investor Call
10. Conseco Declines Partnerships Request for Board Seats; Review of Strategic Alternatives Underway
11. Conseco Reports Preliminary Fourth Quarter and Year-End Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...4 CareTech Solutions , an informa... provider for hospitals and health systems, announ...es earned ten awards in the Strategic Communicati...e awards were accepted by CareTech Solutions Execu...Catallo, at the 13th annual Greystone Internet Hea...
(Date:12/4/2009)...an be an effective way to improve moderate to seve... university Karolinska Institutet report. Those wi...ted most from weight loss. , "Our findings sugg... strategy for sleep apnoea in obese men," says Kar...e study. , Sleep apnoea the temporary cessation...
(Date:12/4/2009)... progress has been made over the last 15 years in ... treat epilepsy and its complications. Yet this p...t of the 50 million people around the world, inclu...e United States who have the disorder, , Accordi...American Epilepsy Society (AES), there is an enorm...
(Date:12/4/2009)...hguard (PPM) - certified Dr. Nassery serves local ... and options , Miami Beac...Dr. H.A. Nassery contributes to local athletic com...young athletes and offering the Pure Power Mouthgu...ated Ashley Kimmel, a student at Miami Country Day...
(Date:12/4/2009)...and what 2-D images represent, researchers say , ...eys can recognize photographs of other monkeys the...ces in faces and figure out if they,ve seen them b...ws that capuchin monkeys can decipher the two-dime...hors noted. , The findings, reported by researc...
Breaking Medicine News(10 mins):Health News:CareTech Solutions Web Clients Earn Top Recognition in the Tenth Annual eHealthcare Leadership Awards Competition 2Health News:CareTech Solutions Web Clients Earn Top Recognition in the Tenth Annual eHealthcare Leadership Awards Competition 3Health News:Weight-loss proves effective cure for sleep apnea 2Health News:Weight-loss proves effective cure for sleep apnea 3Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 3Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 4Health News:Miami Dentist Dr. H.A. Nassery Treats Local Teen Golf Star and Helps Improve Her Performance 2
...hed in the medical journal Thorax a study conclude...culosis infection. The study looked at 2,401 adult...frica. The participants were surveyed about their ... Of 1,309 current smokers or ex-smokers, 1,070...
...ug Administration (FDA) issued a public health adv...ers about the suspended marketing of Tysabri (nata...f multiple sclerosis (MS) which was approved by th...ever, it is believed that the drug has a promising...
...hat is often done as a measure for weight reductio...rt disease. One of the most common procedure...urgery that reduces the size of the stomach and al...s to control obesity through lasting weight loss. ...
...ew discovery regarding the cells that are responsi...searchers from Wake Forest University School of Me... the thalamus area of the brain can slow the relea...tective glutamate receptors in increasing their po...
...er Cancer Institute and collaborating institutions... cancer cells where cancer-related genes may lurk....urnal Cancer Research, the researchers used single...nes were either left out or multiplied over and ov...
...cessfully treat atherosclerosis, the narrowing of ...rmine whether the drugs could also treat a similar...rrowing of the aortic valve in the heart. ...osis. For the study researchers from the United Ki...
Other Medicine News:Health News:Possible location of lung cancer genes found 2
(Date:12/4/2009)..., , WILMINGTON, Del., Dec. 4 /PRNewswire-...ounced that the US Food and Drug Administration (F...tiapine fumarate) Extended Release Tablets as adju...ults with Major Depressive Disorder (MDD). SEROQUE...by the FDA to treat both major depressive disorder...
(Date:12/3/2009)..., , ALISO VIEJO, Calif. and STATE COLLEG...SoftGenetics today announced the signing of an agr... services using SoftGenetics, NextGENe software fo... Ambry. ,, (Logo: http://www.newscom.com/cg...sheidt PhD, Ambry,s CSO said, "Our team at Ambry h...
(Date:12/3/2009)..., , SAN DIEGO, Dec. 3 /PRNewswire-FirstCa...nounced today that it has entered into a new lease...GN ) for approximately 131,000 square feet of addi...ace at The Landmark at Eastview campus in Tarrytow...3. This lease of additional space was completed ap...
Breaking Medicine Technology:US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3Helix BioPharma Announces 2413 5 Million Private Placement 13855 1Helix BioPharma Announces 2413 5 Million Private Placement 13855 2Researchers design new graphene based nanomaterial with magnetic properties 13854 1Researchers design new graphene based nanomaterial with magnetic properties 13854 2HCC Life Insurance Company Renames Short Term Medical Insurance 56237 1HCC Life Insurance Company Renames Short Term Medical Insurance 56237 2
...TLE, Dec. 6 Results from RESTORE 2, a,placebo-con...estigational,compound retigabine significantly red... refractory partial-onset epilepsy when a 600 mg o...i-epileptic drug (AED) therapy. Prior to,enrollmen... experiencing,seizures despite taking stable doses...
...ADELPHIA, Dec. 6 GlaxoSmithKline (NYSE: GSK ),a... RAISE (RAndomized placebo-,controlled ITP Study w...,(eltrombopag) in adults with chronic immune (idio...eived one or more prior ITP therapies. Patients,re... those on placebo to,maintain platelet counts betw...
Other Medicine Technology:Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 2Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 3Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 4Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 5GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 2GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 3GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 4GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 5GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 6GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 7GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 8
ABL80 FLEX Blood Gas Analyzer
Paradigm REAL-Time Insulin Pump and Continuous Glucose Monitoring System
IEC CL40R Centrifuge
IEC CL30R Centrifuge
Medicine Products: